Last edition
News about "inflammation "
AbbVie Announces Acquisition of Celsius Therapeutics
AbbVie has acquired Celsius Therapeutics, Inc., a privately held biotechnology company pioneering new therapies for patients with inflammatory disease.
Inflammation | 29/06/2024 | By Aishwarya | 198
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members